Navigation Links
Most Cancer Treatment Studies Aren't Published, Study Finds
Date:9/15/2008

many unpublished studies contain important information that could influence future research and present practice policy."

There are several reasons why registered trials may not be published. Some trials may fail to meet recruitment or follow-up goals. If the trial is completed and the results are negative, researchers may feel that negative studies do little to advance scientific understanding, or to enhance their professional reputation. Sponsors may not encourage researchers to publish negative results. For their part, medical journal editors may be less enthusiastic about negative studies.

However, publication of negative studies is important for several reasons -- not only to avoid repeating negative trials, but also for what can be learned from the lack of response. "Unpublished trials may have special importance in oncology, due to the toxicity and/or expense of many therapies," the researchers add. The fact that so much cancer research goes unpublished raises concerns about the completeness of available information on present and future cancer treatments.

A pair of accompanying editorials comment on the underpublication of cancer treatment studies, and suggest some approaches to addressing the problem. Dr. James H. Doroshow of the National Cancer Institute (NCI) reports on efforts to develop a database of administrative and outcomes data for all studies performed at NCI-supported institutions.

Drs. Gregory A. Curt and Bruce A. Chabner, Senior Editor and Editor-in-Chief of "The Oncologist," echo the call for increased NCI involvement in ensuring publication of funded studies. Meanwhile, the editors of "The Oncologist" are considering publication of a new, peer-reviewed, fully searchable venue for cancer treatment studies that would otherwise go unpublished. "There is a need for a new venue for publishing all well-executed trials that fail to meet positive endpoints: 'negative' in a sense, but valuable nonetheless," Dr. Curt commen
'/>"/>

SOURCE AlphaMed Press
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... N.J. , May 21, 2013  Armada ... launch of the new Armada corporate website ( ... clearly communicate Armada,s unique and first-to-market services and ... company focused on the specialty pharmacy industry. ... expansion of the Armada business model in delivering ...
(Date:5/21/2013)... SANTA CLARA, Calif. , May 21, ... a game-changing embedded-ultrasound platform, today announced the ... Toolkit that allows complete network-based communications with ... demonstrate its latest embedded-ultrasound technology, including this ... Sao Paulo, Brazil ...
(Date:5/21/2013)... May 21, 2013 Hurel Corporation ("Hurel"), a ... cell-based assay platforms, today announced the appointment of ... the Company,s Board of Directors. Dr. MacDonald is the ... Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development ... Merck & Co. in 2009. Over a ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... Chuck Wielgus, Executive Director of USA Swimming, was named ... ceremony held in conjunction with the Wound, Ostomy and ... Orleans, LA.  The Great Comebacks® Program, which provides support ... to ostomy surgery, annually honors outstanding individuals who are ...
... Four-time NASCAR Cup Series champion Jeff Gordon, known ... he is for his philanthropic activities and tireless support ... the Alabama tornado relief effort through the Jeff Gordon ... clothing for babies and children affected by the destruction. ...
Cached Medicine Technology:Great Comebacks® Program Recognizes National Award Winners 2Great Comebacks® Program Recognizes National Award Winners 3Great Comebacks® Program Recognizes National Award Winners 4Great Comebacks® Program Recognizes National Award Winners 5Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 2Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 3Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 4Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 5
(Date:5/21/2013)... Octo Consulting Group, an award-winning ... solutions to the Federal marketplace, has named Tracy ... the newly created role, Denny will be responsible ... firm’s business development function to include business development ... leading strategies to achieve the firm’s strategic growth ...
(Date:5/21/2013)... News) -- Aggressive treatment for prostate cancer may ... underlying medical conditions, a new study finds. ... and radioactive seed implants, can cause serious side ... bowel problems, explained researchers from the University of ... that older patients with slower growing forms of ...
(Date:5/21/2013)... A study of veterans at high risk for developing ... be highly effective in helping clinicians spot tiny lung ... indicate the earliest stages of the disease. LDCT uses ... conventional CT scan. , Results of the study will ... "Lung cancer is the leading cause of cancer-related death ...
(Date:5/21/2013)... In adults with chronic kidney disease (CKD), ... CKD progression and transplant failure. Now, a first-of-its-kind study ... University has found a possible similar effect in children ... , The study of 366 children aged 1 ... effect of secondhand smoke exposure in CKD, according to ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Finding early ... but a new study adds to a growing body ... may help spot the beginnings of disease in high-risk ... risk for lung cancer, 6 percent were found to ... biopsies to confirm the diagnosis. CT scans detect abnormalities ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3
... a senior citizen,s health, yet fewer than half of all seniors ... medical attention are far less likely to engage in any of ... their medications or getting a cane or walker that might ... UCLA Center for Health Policy Research. In the ...
... was true for males tying the knot with younger females, study ... men seven to nine years their junior could be upping their ... with a significantly younger guy raises a woman,s risk of death ... 12 issue of Demography . , Not that marrying much ...
... ... records between doctors is the latest expansion of the affiliation between The Mount Sinai Medical ... and most comprehensive ear, nose, and throat, allergy and audiology practice in the tri-state area. ... New York, NY (Vocus) ...
... Scientists at The Wistar Institute offer a new explanation for ... the reasons why melanoma remains the deadliest form of skin ... explain why melanoma cells behave like both conventional tumor cells ... May 14 issue of the journal Cell thatcontrary ...
... held promise for building new organs to replace damaged livers, ... is getting cells grown in a lab dish to form ... MIT-Harvard Division of Health Sciences and Technology (HST) have come ... encapsulating living cells in cubes and arranging them into 3-D ...
... will continue validating its ToxCast screening tool by ... GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered ... levels of toxicity when the pharmaceutical companies conducted ... Food and Drug Administration as part of the ...
Cached Medicine News:Health News:Falls and follow-ups: Medical attention following a fall critical to senior health 2Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Mount Sinai Medical Center and ENT & Allergy Associates, LLP Create First-Of-Its-Kind Physician Portal 2Health News:Mount Sinai Medical Center and ENT & Allergy Associates, LLP Create First-Of-Its-Kind Physician Portal 3Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 2Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 3Health News:Tissue engineers create a new way to assemble artificial tissues 2Health News:Tissue engineers create a new way to assemble artificial tissues 3Health News:Pharmaceutical companies provide EPA 100 drugs to help predict toxicity 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: